Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

HIV can cause unusual and severe skin problems that are hard to treat.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Chitosan microparticles improve minoxidil sulphate delivery, potentially reducing daily applications.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Platelet-rich treatments can help improve wound healing and tissue repair.

1α,25-dihydroxyvitamin D3 directly affects cartilage growth and development.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Zinc helps manage skin disorders and deficiencies can worsen some conditions.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Using SNP array testing helped quickly find the gene causing Woodhouse-Sakati syndrome in two related individuals.

The tobacco leaf extract may help hair grow and could treat hair loss.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.